Fortitech, BASF dissolve premix venture

By Lorraine Heller

- Last updated on GMT

Related tags: Basf, Joint venture, Nutrition

The divestiture of a joint venture between BASF and Fortitech will
have no impact on customers, said Fortitech, which confirmed that
it will continue to make its nutrient premixes with the same

The two nutraceutical ingredient firms had joined forces in 2002, creating a venture for the manufacture, marketing and sales of human nutrition premix products. The agreement involved BASF becoming the primary supplier of a broad range of nutritional ingredients to Fortitech for use in a variety of products, including baby formulas, nutrient bars, drinks, and supplements. The ingredients supplied included vitamins, minerals, amino acids, nucleotides, nutraceuticals and other specialty ingredients. However, the two companies last week announced they had dissolved their joint venture, with Fortitech set to buy all BASF shares. The divestiture extends to all joint ventures throughout Europe, South America and Asia, said the firms. According to BASF, the move is part of its strategy to "operate efficiently and flexibly"​ and to position itself as a sustainable ingredient supplier to the food industry. On its end, Fortitech said it is adjusting the way it does business in Europe, South America and Asia as its customer base in those regions continues to grow. "The best way to continue to deliver top-notch service that our customers have come to expect from us is to focus on our core strength as a manufacturer of custom nutrient premix systems,"​ said the company's president and CEO Walter Borisenok. Despite the divestiture of their joint venture, the two companies will continue to work together under a regular supply agreement. BASF will continue to supply nutritional ingredients to Fortitech for use in a variety of custom nutrient blends. Fortitech said that customers will in no way be affected by the move. "In terms of the way we do business, there is nothing that will change, everything will be seamless. We have a number of suppliers around the world that we work with, one of which is BASF,"​ the firm told Fortitech said that to date it has developed over 20,000 custom nutrient premixes. These address a wide range of conditions, including gut health, heart disease, diabetes, bone health and brain health.

Related news

Show more

Related products

show more

Does my Nutraceutical Need a Clinical Trial?

Does my Nutraceutical Need a Clinical Trial?

dicentra – CRO and regulatory consulting firm | 03-Aug-2020 | Technical / White Paper

The global nutraceutical industry is growing at an unprecedented rate. However, companies preparing to bring new and innovative products to the burgeoning...

Supporting cardiovascular health with probiotics

Supporting cardiovascular health with probiotics

Deerland Probiotics & Enzymes | 03-Aug-2020 | Technical / White Paper

Throughout the last decade, researchers have investigated the role of the gut microbiota in the development of cardiovascular disease. Evidence exists...

Related suppliers

Follow us


View more